Announce Date | 04/23/2025 |
EPS Normalized Actual | $1.25 (Beat by $0.334) |
EPS GAAP Actual | $1.25 (Beat by $0.334) |
Revenue Actual | $5.01B |
Revenue Surprise | Beat by $5010M |
Announce Date | 12/31/1969 (Pre-Market) |
EPS Normalized Estimate | $ |
EPS GAAP Estimate | $ |
Revenue Estimate | $0B |
Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
---|---|---|---|---|---|
Dec 2029 | 2.1244 | 27.86 | 1.78748 | 2.42416 | 4 |
Dec 2028 | 2.48 | 23.86 | 2.14478 | 2.95887 | 6 |
Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
---|---|---|---|---|---|
FQ1 2025 (Mar 2025) | 1.68 | 1.68 | 5.01B | 100% | 5010M |
FQ4 2024 (Dec 2024) | 0.0157 | 0.0157 | 0B | -INF% | 0M |
FQ3 2024 (Sep 2024) | -0.874 | -0.874 | -8.312B | 129.99% | -8312M |
FQ2 2024 (Jun 2024) | 0 | 0 | 0B | -INF% | 0M |
FQ1 2024 (Mar 2024) | 0 | 0 | 0B | -INF% | 0M |
FQ4 2023 (Dec 2023) | -3.21 | -3.21 | 3.957B | 19.13% | 3957M |
FQ3 2023 (Sep 2023) | 0.2 | 0.2 | 2.493B | -5.66% | 2493M |
FQ2 2023 (Jun 2023) | 0.58 | 0.58 | 2.683B | -13.98% | 2683M |
FQ4 Announce Date
12/31/1969 (Pre-Market)
Consensus EPS Estimates
Consensus Revenue Estimates
0B
Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ1 2029 (Mar 2029) | 2.1244 | -- | 2.1244 | 2.1244 | 1 |
FQ3 2028 (Sep 2028) | 0.8186 | -- | 0.76882 | 0.85963 | 2 |
FQ2 2028 (Jun 2028) | 0.8128 | -- | 0.76338 | 0.85354 | 2 |
FQ1 2028 (Mar 2028) | 0.8087 | -- | 0.75952 | 0.84924 | 2 |
FQ4 2027 (Oct 2027) | 0.7415 | -- | 0.73322 | 0.74978 | 1 |
FQ3 2027 (Jul 2027) | 0.7286 | -- | 0.72046 | 0.73674 | 1 |
FQ2 2027 (Jun 2027) | 0.7104 | -- | 0.70804 | 0.71275 | 1 |
FQ1 2027 (Mar 2027) | 0.7064 | -- | 0.70406 | 0.70874 | 1 |
FQ4 2026 (Oct 2026) | 0.6517 | -- | 0.64442 | 0.65898 | 1 |
FQ3 2026 (Jul 2026) | 0.65837 | -- | 0.65101 | 0.66573 | 1 |
FQ2 2026 (Jun 2026) | 0.56777 | -- | 0.56589 | 0.56965 | 1 |
Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ1 2029 (Mar 2029) | 10.37B | -- | 10.37B | 10.37B | 3 |
FQ3 2028 (Sep 2028) | 3.94B | -- | 3.76B | 4.1B | 1 |
FQ2 2028 (Jun 2028) | 4.04B | -- | 3.85B | 4.2B | 1 |
FQ1 2028 (Mar 2028) | 4.14B | -- | 3.94B | 4.3B | 1 |
FQ4 2027 (Oct 2027) | 4.8B | -- | 4.76B | 4.84B | 0 |
FQ3 2027 (Jul 2027) | 4.74B | -- | 4.7B | 4.78B | 0 |
FQ2 2027 (Jun 2027) | 17.64B | -- | 17.6B | 17.68B | 0 |
FQ1 2027 (Mar 2027) | 16.66B | -- | 16.62B | 16.7B | 0 |
FQ4 2026 (Oct 2026) | 4.33B | -- | 4.29B | 4.37B | 0 |
FQ3 2026 (Jul 2026) | 4.37B | -- | 4.33B | 4.41B | 0 |
FQ2 2026 (Jun 2026) | 4.38B | -- | 4.37B | 4.39B | 0 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
4
EPS # of Misses
2
EPS # of in-lines
2
Revenue # of Beats
4
Revenue # of Misses
1
Revenue # of in-lines
3
Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ1 2025 (Mar 2025) | 1.68 | 1.68 | 100% | |
FQ4 2024 (Dec 2024) | 0.0157 | 0.0157 | 100% | |
FQ3 2024 (Sep 2024) | -0.874 | -0.874 | 100% | |
FQ2 2024 (Jun 2024) | 0 | 0 | NAN% | |
FQ1 2024 (Mar 2024) | 0 | 0 | NAN% | |
FQ4 2023 (Dec 2023) | -3.21 | -3.21 | 100% | |
FQ3 2023 (Sep 2023) | 0.2 | 0.2 | 100% | |
FQ2 2023 (Jun 2023) | 0.58 | 0.58 | 100% |
Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ1 2025 (Mar 2025) | $0B | $5.01B | $5010M | 100% |
FQ4 2024 (Dec 2024) | $0B | $0B | $0M | NAN% |
FQ3 2024 (Sep 2024) | $0B | $-8.31B | $-8312M | 100% |
FQ2 2024 (Jun 2024) | $0B | $0B | $0M | NAN% |
FQ1 2024 (Mar 2024) | $0B | $0B | $0M | NAN% |
FQ4 2023 (Dec 2023) | $0B | $3.96B | $3957M | 100% |
FQ3 2023 (Sep 2023) | $0B | $2.49B | $2493M | 100% |
FQ2 2023 (Jun 2023) | $0B | $2.68B | $2683M | 100% |